We have a highly experienced Board and Senior Executive Team. The Board sets the Company’s strategy and policies, and monitors progress towards meeting our objectives. This includes regular reviews of financial performance and critical business issues.
The Board
-
Louis Schweitzer
Non-Executive Chairman
Chairman of the Nomination and Governance Committee, member of the Remuneration Committee
Appointed 11 March 2004
Simon Lowth
Executive Director
Chief Financial Officer
Appointed 5 November 2007
Jane Henney
Non-Executive Director
Member of the Audit Committee, the Nomination and Governance Committee and the Science Committee
Appointed 24 September 2001
Bo Angelin
Non-Executive Director
Member of the Science Committee
Appointed 25 July 2007
John Varley
Non-Executive Director
Chairman of the Remuneration Committee, member of the Nomination and Governance Committee
Appointed 26 July 2006
Jean-Philippe Courtois
Non-Executive Director
Member of the Audit Committee
Appointed 18 February 2008
-
David Brennan
Executive Director
Chief Executive Officer
Appointed 14 March 2005
Marcus Wallenberg
Non-Executive Director
Appointed 6 April 1999
Dame Nancy Rothwell
Non-Executive Director
Chairman of the Science Committee, member of the Remuneration Committee
Appointed 27 April 2006
Michele Hooper
Senior Non-Executive Director
Member of the Audit Committee, member of the Nomination and Governance Committee
Appointed 1 July 2003
John Buchanan
Non-Executive Director
Chairman of the Audit Committee, member of the Remuneration Committee
Appointed 25 April 2002
Rudy Markham
Non-Executive Director
Member of the Audit Committee
Appointed 12 September 2008
| Board Committee remits |
|---|
The remits for AstraZeneca's Board Committees are available to view/download here: |
26.95 GBP
